北脑二号
Search documents
肩负使命担当 投身强国建设
Xin Lang Cai Jing· 2026-02-10 22:11
Group 1 - Xi Jinping visited the National Innovation Park in Beijing, emphasizing the importance of technological innovation and encouraging researchers and tech entrepreneurs to contribute to national modernization [2][4] - The National Innovation Park has attracted 1,000 companies, with a focus on cutting-edge fields such as quantum information, 6G communication, and smart hardware [4] - Companies like Beijing Lingzu Times Technology and Beijing Brain Science and Brain-like Research Institute expressed motivation from Xi's visit, highlighting the need for continuous innovation and tackling significant technological challenges [3][5] Group 2 - The emphasis on "self-reliance and self-improvement in technology" was a key message from Xi, inspiring organizations to focus on original innovation and breakthrough technologies [4][5] - The Beijing Quantum Information Science Research Institute aims to lead in quantum technology research, integrating it with artificial intelligence to enhance technological capabilities [8][9] - The robotics sector, represented by companies like Shurui Robotics, is committed to overcoming technical challenges and contributing to China's technological independence [9][10] Group 3 - The "14th Five-Year Plan" outlines goals for Beijing to become a global hub for scientific innovation, focusing on high-level talent and open innovation [12] - The National Blockchain Technology Innovation Center is dedicated to ensuring that China's blockchain technology remains globally competitive, addressing critical issues in the field [12] - The overall sentiment among tech companies is one of determination to fulfill Xi's vision for a technologically advanced nation, with a strong focus on practical applications and real-world problem-solving [10][11]
北京脑科学与类脑研究所所长、神经生物学家罗敏敏:建议建立侵入式脑机接口技术高标准监管体系
Zheng Quan Ri Bao· 2026-01-28 16:11
脑机接口技术作为生命科学与信息科学深度融合的交叉前沿技术,已成为全球科技竞争的新焦点。 2026年伊始,脑机接口"独角兽"浙江强脑科技有限公司宣布完成约20亿元的C轮融资。此次融资不仅创 下了脑机接口赛道除马斯克旗下Neuralink之外的全球第二大单笔融资纪录,也显示出资本对脑机接口产 业发展的强烈信心。 与此同时,从国家层面到地方政府,一系列涵盖产业培育、医疗服务定价等关键环节的利好政策相继出 台,为行业注入了强劲的推动力。产业、资本与政策同频共振,将脑机接口推至前所未有的热度。 在这幅火热的行业图景背后,一系列核心问题亟待厘清:中国脑机接口的真实发展水平究竟如何?与国 际前沿相比,我们的优势与差距何在?产业跃进的道路上,还有哪些核心瓶颈需要突破?带着这些问 题,记者走进"北脑一号"与"北脑二号"的诞生地——北京脑科学与类脑研究所(以下简称"北脑所"),与 北脑所所长、神经生物学家罗敏敏进行深入探讨。 追赶与超越 "在脑机接口领域,我国与其他国家在原理理论、技术积累、系统集成、临床应用等诸多方面还存在一 定差距。但是这种差距正在不断缩小。"罗敏敏对《证券日报》记者说,"过去几年,我国脑机接口技术 进展显著 ...
两院院士评出2025中国十大科技进展:“人造太阳”创世界纪录等入选
Xin Lang Cai Jing· 2026-01-26 09:43
Core Insights - The announcement of the 2025 Top Ten Scientific Advances in China highlights significant achievements in various fields, including nuclear fusion, artificial intelligence, and advanced medical technologies [1][9]. Group 1: Nuclear Energy and Fusion - The Chinese "artificial sun" (EAST) achieved a world record by maintaining a temperature of 100 million degrees Celsius for 1066 seconds, marking a significant leap from basic science to engineering practice in fusion energy research [1][3]. - The thorium molten salt reactor, developed by the Shanghai Institute of Applied Physics, successfully converted thorium into uranium fuel, becoming the only operational molten salt reactor utilizing thorium, thus reinforcing China's leadership in this research area [3][5]. Group 2: Artificial Intelligence - DeepSeek, a company established just over a year ago, launched a new generation AI model R1, which matches the performance of OpenAI's models while achieving significantly lower training costs and being fully open-sourced, creating a major impact in the global AI landscape [3]. Group 3: Medical Innovations - A high-precision AI diagnostic tool for predicting liver cancer recurrence, developed by a research team from the University of Science and Technology of China, achieved an accuracy rate of 82.2% and was featured on the cover of Nature, marking a new direction in computational tumor immunology [5][6]. - The "North Brain No. 1" system, a wireless brain-computer interface, successfully helped patients with speech loss due to ALS regain communication abilities, representing a significant advancement in neurotechnology [6]. Group 4: Quantum Computing - The "Zu Chongzhi III" superconducting quantum computing prototype was developed, demonstrating a processing speed that is a trillion times faster than the fastest supercomputers, showcasing significant advancements in quantum computing capabilities [6][8]. Group 5: Hydrogen Production and Environmental Technology - A new hydrogen production method was developed by a team from Peking University, which eliminates carbon dioxide emissions at the source, contributing to zero-carbon hydrogen production [8]. - The "Black Soil Granary" technology campaign achieved breakthroughs in black soil protection, supporting national strategies for sustainable agricultural practices [8]. Group 6: Communication Technology - A joint team from Peking University and City University of Hong Kong developed an ultra-broadband optoelectronic integrated system for 6G communication, enabling high-speed wireless communication across all frequency bands, which will enhance the reliability and intelligence of future wireless networks [8].
国有企业质量效益全面提升
Sou Hu Cai Jing· 2026-01-19 23:16
Core Viewpoint - The meeting held by the State-owned Assets Supervision and Administration Commission (SASAC) highlighted the significant improvements in the quality and efficiency of state-owned enterprises (SOEs) during the 14th Five-Year Plan period, with total assets of regulated enterprises increasing from 235 trillion yuan to 387 trillion yuan, reflecting an average annual growth of 10.5% [1] Group 1: Enhancements in Enterprise Competitiveness - By November 2025, local regulated enterprises achieved a value-added of 6.9 trillion yuan and completed fixed asset investments of 5.3 trillion yuan, contributing positively to economic growth and public welfare [2] - SASAC Director Zhang Yuzhuo emphasized the continuous strengthening of technological innovation within SOEs, with 16 local SASACs establishing evaluation systems for R&D input and output [2] - Traditional industries are undergoing quality upgrades while emerging industries are being nurtured, with provinces like Henan and Shandong implementing strategic plans for transformation and development [2] Group 2: Reform and Governance Improvements - The deepening of SOE reforms has led to optimized governance structures and improved market mechanisms, with local governments actively promoting reform initiatives [3] - The effectiveness of state asset supervision has been enhanced, with the establishment of a national property information database and comprehensive coverage of property registration systems [3] - Over the past five years, SOEs have seen increased vitality and competitiveness, contributing significantly to national strategies and infrastructure development [3] Group 3: Focus on Quality and Efficiency - The quality and efficiency of SOEs are crucial for the overall economic and social development of China, with a focus on creating value and improving operational metrics [4] - Key objectives for the 15th Five-Year Plan include enhancing value creation, technological innovation, and industrial upgrading capabilities [4][5] - Emphasis is placed on reform breakthroughs, strengthening party leadership, and ensuring effective governance to support high-quality development [5] Group 4: Future Development Directions - For 2026, SOEs are expected to focus on quality enhancement and steady growth, with initiatives to create new consumption scenarios and implement key projects to stimulate demand [6] - Strengthening the role of SOEs in technological innovation and optimizing the economic layout and structure are prioritized [6][7] - Local SASACs are urged to implement further reforms and improve market-oriented operational mechanisms while preventing systemic risks [7]
“十四五”时期国资系统监管企业资产总额年均增长10.5% 国有企业质量效益全面提升
Sou Hu Cai Jing· 2026-01-19 22:38
国务院国资委日前召开的地方国资委负责人会议介绍,"十四五"时期,我国国有企业质量效益全面提 升,国资系统监管企业资产总额从235万亿元增至387万亿元,年均增长10.5%,有力支撑了我国经济社 会持续健康发展。 国务院国资委主任张玉卓在会上表示,2025年,国资国企科技创新持续强化,创新机制不断完善,创新 生态持续优化,在推进科技自立自强中实现了新突破。16个地方国资委建立研发投入产出评价制度;湖 南省全年完成85项关键核心技术攻关,取得全球最大吨位4000吨级全地面起重机、世界首台(套)220 吨级纯电矿用自卸车等18项重要成果。 传统产业提质升级,新兴产业培育壮大,未来产业前瞻布局,在建设现代化产业体系中展现新作为。例 如,河南省制定实施煤炭、钢铁、煤化工等重点行业转型升级方案,大力推动企业技术改造、行业资源 整合、产业布局优化;山东省开展战略性新兴产业培育发展三年行动、梯次培育行动,遴选170余个项 目,实行分级管理和精准赋能;北京市积极布局脑机接口、具身智能等未来产业,"北脑二号"填补国内 脑机接口技术空白,全国首个通用人形机器人母平台"天工"正式运行。 "国有企业发展质量效益的高低,直接关系我国经济 ...
脑机接口商业化蓄势待发
Jing Ji Ri Bao· 2026-01-18 22:15
Core Insights - The clinical transformation speed of brain-computer interface (BCI) technology is accelerating, with China's semi-invasive BCI "Beina No. 1" implanted in six patients and invasive products like "Beina No. 2" expected to enter clinical trials by 2026 [1] - The industry is entering a critical phase of clinical value verification and early commercialization, driven by strong policy support, high capital interest, and urgent clinical demand, while facing challenges from international competition and ethical controversies [1] Policy Framework - In 2023, the Ministry of Industry and Information Technology (MIIT) established a BCI track under the "Future Industry Innovation Task" and released a plan for standardization from 2023 to 2035 [2] - By 2025, multiple provinces in China have included BCI technology in their charging catalogs, paving the way for future clinical applications [2] Local Initiatives - Various provinces, including Beijing, Shanghai, and Shandong, have introduced special policies to support BCI industry development, with Shanghai focusing on creating specialized incubators [3] - The Tianjin Binhai High-tech Zone has also implemented supportive policies for BCI industrialization [3] Clinical Validation - BCI technology is categorized into invasive, non-invasive, and semi-invasive types, with invasive and semi-invasive technologies becoming core breakthroughs in medical rehabilitation [4] - The most mature application of BCI technology is in medical rehabilitation, particularly in restoring motor and speech functions [4] Application Expansion - The application scenarios for BCI technology are diversifying, with invasive BCIs focusing on medical settings and non-invasive BCIs being tested in various fields such as industrial safety and education [7] - Non-invasive BCIs are being piloted in industrial safety to monitor fatigue among operators, while consumer-grade applications are emerging in education and entertainment [7] Market Development - The consumer market for BCI technology is still in its nurturing phase, with products like brainwave headphones and brain-controlled gaming devices lacking sufficient user experience [8] - The medical rehabilitation sector is expected to dominate the market in the next five years, while consumer and industrial products will rely on technological breakthroughs for wider adoption [8] Industry Challenges - BCI technology faces challenges in core technology, application scenarios, market competition, and industry ecology, necessitating policy guidance and standardization [9] - Key technological breakthroughs in biocompatible flexible electrodes and AI decoding algorithms are essential for practical implementation [9] Technological Advancements - BCI technology is undergoing rapid iterative upgrades, with advancements in hardware and software, as well as interdisciplinary innovations in materials science and chip design [10] - The enhancement of full-chain technological capabilities will facilitate the transition of BCI systems from laboratory research to practical applications [10]
资金和政策协同发力 脑机接口技术落地与商业化提速并进
Sou Hu Cai Jing· 2026-01-13 08:38
Core Insights - The article discusses the rapid advancement and commercialization of brain-computer interface (BCI) technology in China, driven by policy support and significant capital investment [1][5][9]. Technological Breakthroughs - Recent breakthroughs in BCI technology include successful clinical trials for invasive systems, enabling high-level paraplegic patients to control devices like smart wheelchairs and robotic dogs [5][6]. - Companies like JieTi Medical and ChipSmart have made significant progress, with JieTi completing three invasive clinical trials and ChipSmart's semi-invasive product achieving successful human implants [5][6]. - The BCI technology is categorized into non-invasive, semi-invasive, and invasive types, each with its advantages and disadvantages [5]. Policy and Capital Support - The Chinese government has identified BCI as one of the six future industries in the 14th Five-Year Plan, providing a strategic framework for its development [8][9]. - Recent policy initiatives include the establishment of independent billing for BCI services by the National Medical Insurance Administration, with several provinces setting clear pricing for BCI medical services [8][9]. - The National Medical Products Administration has also initiated standards for BCI technology, which will help reduce costs and risks associated with clinical applications [8][9]. Market Opportunities - The BCI market is expected to grow significantly, with a focus on medical applications for conditions like stroke, epilepsy, and paralysis, where patients show a strong willingness to adopt early products [6][7]. - The integration of BCI technology with artificial intelligence and robotics could open up a trillion-dollar market space in the long term [11]. Industry Standardization - The BCI industry is anticipated to move towards standardization and scalability, with initial industry standards expected to be established by 2027-2028 [10]. - The domestic BCI industry benefits from strong policy support, a vast clinical resource base, and a complete supply chain, which are crucial for its growth [10]. Investment Landscape - Investment firms highlight the dual nature of BCI as both a medical and technology investment, emphasizing the importance of identifying policy-supported "true BCI" targets [11]. - The potential for leading Chinese BCI companies to emerge on the global stage is significant, given the country's advancements in technology and supportive investment environment [11].
政策资本双轮驱动 脑机接口技术落地与商业化提速并进
Zhong Guo Zheng Quan Bao· 2026-01-12 20:49
Core Insights - The brain-computer interface (BCI) industry in China is experiencing significant advancements, with clinical results emerging for high-level paraplegics and substantial funding rounds, including a recent 2 billion yuan investment in a non-invasive unicorn company, Strong Brain Technology, marking the second-largest funding record globally in this field [1][2] - The industry is poised for rapid commercialization, driven by technological breakthroughs, capital influx, and supportive policies, as it transitions from cutting-edge technology to practical applications in daily life [1][5] Technological Breakthroughs - Recent advancements in BCI technology include successful clinical trials for invasive systems, enabling high-level paraplegics to control smart wheelchairs and robotic dogs [2][3] - Companies like JieTi Medical and Chip Intelligence have made significant progress, with JieTi completing trials for its invasive BCI system and Chip Intelligence's semi-invasive product achieving human implantation [2][3] - The first clinical trial of a fully implanted, wireless BCI product by Brain Tiger Technology has shown promising results, allowing an 8-year paraplegic patient to achieve thought control just five days post-surgery [2][3] Policy and Capital Support - The BCI sector benefits from comprehensive policy support, including its designation as one of the six future industries in the 14th Five-Year Plan, which elevates it to a national strategic priority [5][6] - Recent initiatives by the Sichuan provincial medical insurance bureau have established pricing for 82 neuro-related medical services, including BCI applications, facilitating clinical adoption [5][6] - The establishment of industry standards by the National Medical Products Administration is expected to lower costs and risks associated with technology development and clinical application [6] Industry Collaboration and Investment - Companies like Baiyang Pharmaceutical are actively collaborating with academic institutions to explore the integration of BCI with artificial intelligence, aiming for innovative clinical solutions [7] - Other listed companies are also engaging in the BCI space through material supply and equipment development, indicating a strong interest from institutional investors [7] Future Development and Challenges - The BCI industry is anticipated to move towards standardization and scalability, with initial industry standards expected to be established by 2027-2028 [8] - Potential constraints include the pace of chip design and production, as well as the need for ethical regulations regarding personal brain data [8] - Despite these challenges, the domestic BCI industry holds significant advantages, including strong policy support, a vast clinical resource base, and a comprehensive supply chain [8] Investment Opportunities - The BCI sector presents a dual investment opportunity in both medical and technological domains, with short-term focus on disease treatment and long-term potential for enhancing human capabilities through integration with AI and robotics [9] - The industry is positioned to cultivate leading global BCI companies, fostering a capital-innovation synergy between primary and secondary markets [9]
北京昌平构筑脑机接口产业高地
Zhong Guo Zheng Quan Bao· 2026-01-12 20:45
Core Viewpoint - Changping District aims to establish a distinctive brain science and brain-computer interface (BCI) industrial cluster by the end of the 14th Five-Year Plan, enhancing its innovation capabilities and comprehensive strength to reach international standards, thus becoming a new growth pole for high-quality regional development [1] Policy and Financial Collaboration - Changping District has introduced the first action plan for the development of brain science and BCI industries in Beijing, creating a "three-level linkage" support system that aligns with national and municipal policies, targeting a scale of a 10 billion yuan industry cluster by 2030 [1][2] - The district has launched various policy measures focusing on technological innovation, enterprise aggregation, and ecosystem construction, providing comprehensive services for innovation entities [2] - A 300 million yuan special fund for brain science and BCI has been established through a partnership between Changfa Group and Daoyuan Capital, promoting a diversified investment model [2] Innovation and Industry Integration - Changping District plans to implement key initiatives in the BCI sector by 2025, including the establishment of the first district-level industrial cluster and park for brain science and BCI in Beijing [3] - The district is developing an "one core one city" industrial layout, with the Zhongguancun Life Science Park as the core for enterprise incubation and achievement transformation [3] Application Potential and Breakthroughs - The BCI sector shows significant application potential in healthcare, wellness, industrial safety, education, and smart living, with Changping District achieving notable breakthroughs in line with the strategic deployment of the 14th Five-Year Plan [4] - Leading companies such as Galaxy Fangyuan and Chipwise have made significant advancements in treating diseases like Parkinson's and Alzheimer's, with innovative products like the "North Brain No. 1" BCI device being recognized as a top innovation [4] Development Plans and Future Initiatives - Changping District has seen the establishment of 28 key enterprises in the BCI sector, forming a collaborative ecosystem that integrates clinical needs, technology research, and product commercialization [5] - Future plans for 2026 include implementing policies to support the BCI industry, accelerating the construction of the industrial cluster, attracting relevant enterprises, and enhancing the investment environment [6]
政策资本双轮驱动脑机接口技术落地与商业化提速并进
Zhong Guo Zheng Quan Bao· 2026-01-12 20:45
Core Insights - The brain-computer interface (BCI) industry in China is experiencing significant advancements, with clinical results emerging for high-level paraplegics controlling devices through thought, and strong financing support from unicorn companies like Strong Brain Technology, which raised approximately 2 billion yuan, marking the second-largest funding record globally in this field [1][2] - The industry is positioned for rapid commercialization, driven by technological breakthroughs, capital influx, and supportive policies, as it transitions from cutting-edge technology to practical applications in daily life [1][2] Technological Breakthroughs - Recent advancements in the BCI field include successful clinical trials for invasive BCIs, with patients able to control smart wheelchairs and robotic dogs, showcasing the technology's potential for enhancing autonomy in daily life [2] - The development of high-throughput wireless invasive BCI systems has been achieved, with significant reductions in signal transmission delays to under 100 milliseconds, facilitating practical applications beyond laboratory settings [2] Market Demand and Application - The initial target demographic for BCI technology includes patients with conditions such as stroke, epilepsy, Parkinson's disease, and paralysis, who show strong willingness to try and pay for early products, indicating a broad medical market potential [3] - Current clinical applications focus on restoring motor and speech functions, with significant progress in motor rehabilitation for patients with spinal cord injuries and strokes, as well as breakthroughs in speech function restoration for patients with severe speech disorders [3] Policy and Capital Support - The BCI industry benefits from comprehensive policy support, including its designation as one of the six future industries in the 14th Five-Year Plan, and specific initiatives from various government departments to promote innovation and development in the sector [4][5] - Recent policy changes in regions like Sichuan have established clear pricing for BCI medical services, enhancing the financial viability of these technologies and facilitating their clinical application [4] Industry Standardization and Future Outlook - The BCI industry is expected to move towards standardization and scalability, with preliminary industry standards anticipated to be established by 2027-2028, paving the way for broader application and brand emergence by 2030 [6][7] - The domestic BCI industry possesses significant advantages, including strong policy support, a vast clinical resource base, and a complete supply chain, which collectively foster the industry's growth [7] Investment Opportunities - The BCI sector presents dual investment attributes in both medical and technological domains, with short-term focus on disease treatment and long-term potential for enhancing human capabilities through integration with AI and robotics, potentially unlocking a trillion-yuan market [7]